Prevalence of Drug-Induced Hepatitis and its Risk Factors in the Treatment of Tuberculosis in TB Infected Patients Attending Razi Hospital, 2006-2011
Author(s):
Abstract:
Background and
Purpose
Hepatotoxicity and elevated serum aminotransferase is a severe side effect of anti-Tuberculosis therapy and some cases could even develop hepatitis. This study aimed at determining the prevalence of drug induced hepatitis and predisposing factor after anti-Tuberculosis therapy in Razi hospital. Materials And Methods
In this cross-sectional study we used the medical records of all confirmed cases of tuberculosis admitted at the infectious disease ward of Ghaemshahr Razi hospital between 2006-2011. Variables included age، sex، type of TB، other medications، basal levels of liver enzymes، enzyme changes during treatment، and co-infection (such as hepatitis B - HIV). The diagnosis of drug induced hepatitis was done with at least five-fold increase of aminotransferase levels. Data was analyzed using SPSS17، chi square tests and Fisher''s exact test. Results
Of 230 patients، 56. 5% were male. The frequency of pulmonary TB and extra pulmonary TB was 91. 7% and 8. 3%، respectively. Standard treatment was used in 92. 5% of patients with tuberculosis. 23. 5% of patients had an underlying disease. Prevalence of drug-induced hepatitis in this study was 9. 5%. There was no significant correlation between gender، type of tuberculosis and type of drug treatment with drug-induced hepatitis، but there was a significant relationship between age and druginduced hepatitis. Conclusion
The results showed that old age was the only significant risk factor for druginduced hepatitis in the treatment of tuberculosis، hence، elderly patients must be placed under regular clinical and laboratory evaluation.Keywords:
Language:
Persian
Published:
Journal of Mazandaran University of Medical Sciences, Volume:23 Issue: 109, 2014
Pages:
236 to 240
magiran.com/p1231437
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
دسترسی سراسری کاربران دانشگاه پیام نور!
اعضای هیئت علمی و دانشجویان دانشگاه پیام نور در سراسر کشور، در صورت ثبت نام با ایمیل دانشگاهی، تا پایان فروردین ماه 1403 به مقالات سایت دسترسی خواهند داشت!
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!